tiprankstipranks
Trending News
More News >
Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
India Market

Dr. Lal PathLabs Limited (LALPATHLAB) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

LALPATHLAB Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Dr.
Lal PathLabs Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LALPATHLAB Stock 12 Month Forecast

Average Price Target

₹3,107.50
▲(6.91%Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Dr. Lal PathLabs Limited in the last 3 months. The average price target is ₹3,107.50 with a high forecast of ₹3,315.00 and a low forecast of ₹2,900.00. The average price target represents a 6.91% change from the last price of ₹2,906.55.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2263":"₹2,263","2828":"₹2,828","3393":"₹3,393","2545.5":"₹2,545.5","3110.5":"₹3,110.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹3.31K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3107.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹3.11K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2900,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹2.90K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2263,2545.5,2828,3110.5,3393],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Sep<br/>2024","9":"Dec<br/>2024","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2398.2,2468.723076923077,2539.246153846154,2609.7692307692305,2680.2923076923075,2750.8153846153846,2821.3384615384616,2891.8615384615387,2962.3846153846152,3032.9076923076923,3103.4307692307693,3173.953846153846,3244.4769230769234,{"y":3315,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2398.2,2452.7615384615383,2507.3230769230768,2561.8846153846152,2616.4461538461537,2671.007692307692,2725.5692307692307,2780.130769230769,2834.6923076923076,2889.253846153846,2943.8153846153846,2998.376923076923,3052.9384615384615,{"y":3107.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2398.2,2436.7999999999997,2475.3999999999996,2514,2552.6,2591.2,2629.7999999999997,2668.4,2707,2745.6,2784.2,2822.8,2861.4,{"y":2900,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2306.14,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2264.12,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2348.46,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2620.28,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2803.19,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3074.27,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3363.89,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3392.51,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3092.07,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3006.17,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3006.17,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3035.3,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2398.2,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target₹3,315Average Price Target₹3,108Lowest Price Target₹2,900
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Nomura
₹3,310₹3,315
Buy
14.05%
Upside
Upgraded
01/31/25
Nomura/Instinet Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to BuyNomura/Instinet analyst Saion Mukherjee upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Neutral to Buy with a price target of INR3,315.00 (from INR3,310.00).
ICICI Securities Analyst forecast on IN:LALPATHLAB
Abdulkader PuranwalaICICI Securities
ICICI Securities
₹3,100₹2,900
Hold
-0.23%
Downside
Reiterated
01/31/25
Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,900 at ICICI SecuritiesICICI Securities analyst Abdulkader Puranwala lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,900.00 (from INR3,100.00) while maintaining a Hold (3) rating.
CLSA
₹3,110₹3,240
Buy
11.47%
Upside
Upgraded
01/23/25
CLSA Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to Outperform (2)CLSA analyst Kunal Lakhan upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Hold (3) to Outperform (2) with a price target of INR3,240.00 (from INR3,110.00).
Kotak Mahindra Analyst forecast on IN:LALPATHLAB
Alankar GarudeKotak Mahindra
Kotak Mahindra
₹3,250
Buy
11.82%
Upside
Upgraded
01/05/25
Kotak Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to Add (2)Kotak analyst Alankar Garude upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Reduce (3) to Add (2) with a price target of INR3,250.00.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Nomura
₹3,310₹3,315
Buy
14.05%
Upside
Upgraded
01/31/25
Nomura/Instinet Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to BuyNomura/Instinet analyst Saion Mukherjee upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Neutral to Buy with a price target of INR3,315.00 (from INR3,310.00).
ICICI Securities Analyst forecast on IN:LALPATHLAB
Abdulkader PuranwalaICICI Securities
ICICI Securities
₹3,100₹2,900
Hold
-0.23%
Downside
Reiterated
01/31/25
Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,900 at ICICI SecuritiesICICI Securities analyst Abdulkader Puranwala lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,900.00 (from INR3,100.00) while maintaining a Hold (3) rating.
CLSA
₹3,110₹3,240
Buy
11.47%
Upside
Upgraded
01/23/25
CLSA Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to Outperform (2)CLSA analyst Kunal Lakhan upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Hold (3) to Outperform (2) with a price target of INR3,240.00 (from INR3,110.00).
Kotak Mahindra Analyst forecast on IN:LALPATHLAB
Alankar GarudeKotak Mahindra
Kotak Mahindra
₹3,250
Buy
11.82%
Upside
Upgraded
01/05/25
Kotak Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to Add (2)Kotak analyst Alankar Garude upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Reduce (3) to Add (2) with a price target of INR3,250.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Lal PathLabs Limited

1 Month
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
-9.10%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -9.10% per trade.
3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
-0.55%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.55% per trade.
1 Year
Success Rate
2/2 ratings generated profit
100%
Average Return
+0.95%
reiterated a buy rating last month
Copying Saion Mukherjee's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +0.95% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+0.95%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +0.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LALPATHLAB Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Apr 25
Strong Buy
0
0
0
Buy
0
2
3
Hold
0
1
1
Sell
1
1
1
Strong Sell
0
0
0
total
1
4
5
In the current month, LALPATHLAB has received 3 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. LALPATHLAB average Analyst price target in the past 3 months is 3,107.50.
Each month's total comprises the sum of three months' worth of ratings.

LALPATHLAB Financial Forecast

LALPATHLAB Earnings Forecast

Next quarter’s earnings estimate for LALPATHLAB is ₹13.65 with a range of ₹13.45 to ₹13.86. The previous quarter’s EPS was ₹13.70. LALPATHLAB beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year LALPATHLAB has Outperformed its overall industry.
Next quarter’s earnings estimate for LALPATHLAB is ₹13.65 with a range of ₹13.45 to ₹13.86. The previous quarter’s EPS was ₹13.70. LALPATHLAB beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year LALPATHLAB has Outperformed its overall industry.

LALPATHLAB Sales Forecast

Next quarter’s sales forecast for LALPATHLAB is ₹6.72B with a range of ₹6.72B to ₹6.72B. The previous quarter’s sales results were ₹6.03B. LALPATHLAB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year LALPATHLAB has Preformed in-line its overall industry.
Next quarter’s sales forecast for LALPATHLAB is ₹6.72B with a range of ₹6.72B to ₹6.72B. The previous quarter’s sales results were ₹6.03B. LALPATHLAB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year LALPATHLAB has Preformed in-line its overall industry.

LALPATHLAB Stock Forecast FAQ

What is IN:LALPATHLAB’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr. Lal PathLabs Limited’s 12-month average price target is 3,107.50.
    What is IN:LALPATHLAB’s upside potential, based on the analysts’ average price target?
    Dr. Lal PathLabs Limited has 6.91% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Dr. Lal PathLabs Limited a Buy, Sell or Hold?
          Dr. Lal PathLabs Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Dr. Lal PathLabs Limited’s share price target?
            The average share price target for Dr. Lal PathLabs Limited is 3,107.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹3,315.00 ,and the lowest forecast is ₹2,900.00. The average share price target represents 6.91% Increase from the current price of ₹2,906.55.
              What do analysts say about Dr. Lal PathLabs Limited?
              Dr. Lal PathLabs Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Dr. Lal PathLabs Limited?
                To buy shares of IN:LALPATHLAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis